ArticleScientific reports2019

Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment.

Grady L Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.